Associate Professor, Internal Medicine, Virginia Commonwealth University, Medical College of Virginia School of Medicine

Gastroenterology

Jasmohan S. Bajaj, MD is an expert in the field of Gastroenterology. He researched medicine at Medical College of Wisconsin Affiliated Hospitals. Jasmohan Bajaj is a published doctor as well. He has 100 publications published. The latest was: Tired of Hepatitis B?

Publications

---

• Tired of Hepatitis B?
• Diagnosing Minimal Hepatic Encephalopathy: From the Ivory Tower to the Real World.
• Covert and Overt Hepatic Encephalopathy: Diagnosis and Management.
• Management of the Critically Ill Patient with Cirrhosis: A Multidisciplinary Perspective.
• Hepatic Encephalopathy Treatment and Driving: A Continental Divide.
• The human gut sterolbiome: bile acid-microbiome endocrine aspects and therapeutics.
• Variations in albumin use in patients with Cirrhosis: An AASLD members survey.
• Salivary Microbiota Reflects Changes in Gut Microbiota in Cirrhosis with Hepatic Encephalopathy.
• Correction of hyponatraemia improves cognition, quality of life, and brain oedema in Cirrhosis.
• Prolonged remission from hepatic encephalopathy with rifaximin: results of a placebo crossover analysis.
• Systems biology analysis of omeprazole therapy in Cirrhosis demonstrates significant shifts in gut microbiota composition and function.
• Cognitive Reserve Is a Determinant of Health-related Quality of Life in Patients With Cirrhosis, Independent of Covert Hepatic Encephalopathy and Model for End-Stage L...
• Supplementation of Saturated Long-chain Fatty Acids Maintains Intestinal Eubiosis and Reduces Ethanol-induced Liver Injury in Mice.
• Covert Hepatic Encephalopathy Is Independently Associated With Poor Survival and Increased Risk of Hospitalization.
• Effects of Obstructive Sleep Apnea on Sleep Quality, Cognition, and Driving Performance in Patients with Cirrhosis.
• Toward an Improved Definition of Acute-on-Chronic Liver Failure.
• Colonic inflammation and secondary bile acids in alcoholic Cirrhosis.
• Commentary: probing probiotics in Cirrhosis - a template for future studies? Author's reply.
• Commentary: TIPSS for Budd-Chiari syndrome.
• Antibiotic Prophylaxis in Acute Liver Failure: Friend or Foe?
• Validation of EncephalApp, Smartphone-based Stroop Test, for the Diagnosis of Covert Hepatic Encephalopathy.
• The role of microbiota in hepatic encephalopathy.
• Bile acids and the gut microbiome.
• Randomised clinical trial: Lactobacillus GG modulates gut microbiome, metabolome and endotoxemia in patients with Cirrhosis.
• Development of a simple and accurate HPLC method for measurement of fecal bile acids: validation by GC-MS and LC-MS and application in healthy and cirrhotic patients.
• Enhancement of functional connectivity, working memory and inhibitory control on multi-modal brain MR imaging with Rifaximin in Cirrhosis: Implications for the gut-liv...
• Survival in infection-related acute-on-chronic liver failure is defined by extra-hepatic organ failures.
• Useful tests for hepatic encephalopathy in clinical practice.
• Diagnosis of Covert Hepatic Encephalopathy Without Specialized Tests.
• The Cirrhosis Dysbiosis Ratio defines Changes in the Gut Microbiome Associated with Cirrhosis and its Complications.
• Effects of N-acetylcysteine on cytokines in non-acetaminophen acute liver failure: potential mechanism of improvement in transplant-free survival.
• Commentary: non-haemodynamic effects of beta-blockers in Cirrhosis - more than meets the eye? Authors' reply.
• Statin use and infections in Veterans with Cirrhosis.
• Non-selective beta-blockers are not associated with serious infections in veterans with Cirrhosis.
• Cirrhosis, bile acids, and gut microbiota: Unraveling a complex relationship.
• Cognitive improvement after HCV eradication: Extending the benefits.
• Differential Impact of Hyponatremia and Hepatic Encephalopathy on Health-Related Quality of Life and Brain Metabolite Abnormalities in Cirrhosis.
• Cognitive Dysfunction is Associated with Poor Socio-Economic Status in Patients with Cirrhosis: an International Multi-Center Study.
• Defining Acute-on-Chronic Liver Failure: Will East and West Ever Meet?
• Commentary: the chronic Hepatitis C virus treatment satisfaction (HCVTSat) instrument.
• Effect of obstructive sleep apnea on the sleep architecture in Cirrhosis.
• Antibiotics for the treatment of hepatic encephalopathy.
• The stroop smartphone APP is a short and valid method toscreen for minimal hepatic encephalopathy.
• Modulation of the fecal bile acid profile by gut microbiota in Cirrhosis.
• Commentary: PPIs and risk of serious infection in decompensated Cirrhosis - authors' reply.
• Covert hepatic encephalopathy: not as minimal as you might think.
• Methanogenesis in Irritable Bowel Syndrome: A Lot of Hot Air?
• Proton pump inhibitors are associated with a high rate of serious infections in veterans with decompensated Cirrhosis.
• Asymmetric Di-methyl Arginine is Strongly Associated with Cognitive Dysfunction and Brain MR Spectroscopic Abnormalities in Cirrhosis.
• Second infections independently increase mortality in hospitalized patients with Cirrhosis: the North American consortium for the study of end-stage liver disease (NAC...
• Cognitive Performance as a predictor of hepatic encephalopathy in pre-transplant cirrhotic patients receiving psychoactive medications: A prospective study.
• Bacterial infections in end-stage liver disease: current challenges and future directions.
• A longitudinal systems biology analysis of lactulose withdrawal in hepatic encephalopathy.
• Diagnosis and treatment of minimal hepatic encephalopathy to prevent motor vehicle accidents: A cost-effectiveness analysis.
• Muscle and mortality in Cirrhosis.
• Linkage of Gut Microbiome with Cognition in Hepatic Encephalopathy.
• Driving Simulation Can Improve Insight into Impaired Driving Skills in Cirrhosis.
• The multi-dimensional burden of Cirrhosis and hepatic encephalopathy on patients and caregivers.
• Diet and cognition in chronic liver disease.
• Rifaximin improves driving simulator performance in a randomized trial of patients with minimal hepatic encephalopathy.
• Advances in the evaluation and management of minimal hepatic encephalopathy.
• What is driving the legal interest in hepatic encephalopathy?
• Drug therapy: rifaximin.
• Persistence of cognitive impairment after resolution of overt hepatic encephalopathy.
• Current and future diagnosis of hepatic encephalopathy.
• Clostridium difficile is associated with poor outcomes in patients with Cirrhosis: A national and tertiary center perspective.
• Spectrum of neurocognitive impairment in Cirrhosis: Implications for the assessment of hepatic encephalopathy.
• Minimal hepatic encephalopathy is associated with motor vehicle crashes: the reality beyond the driving test.
• Association of proton pump inhibitor therapy with spontaneous bacterial peritonitis in cirrhotic patients with ascites.
• The effect of fatigue on driving skills in patients with hepatic encephalopathy.
• Failure to fully disclose during pretransplant psychological evaluation in alcoholic liver disease: a driving under the influence corroboration study.
• Inhibitory control test for the diagnosis of minimal hepatic encephalopathy.
• Patients with minimal hepatic encephalopathy have poor insight into their driving skills.
• Endoscopic band ligation of Esophageal varices in patients on anticoagulation.
• Deleterious effect of Cirrhosis on outcomes after motor vehicle crashes using the nationwide inpatient sample.
• Probiotic yogurt for the treatment of minimal hepatic encephalopathy.
• Navigation skill impairment: Another dimension of the driving difficulties in minimal hepatic encephalopathy.
• Minimal hepatic encephalopathy: a vehicle for accidents and traffic violations.
• Prospective, randomized trial comparing effect of oral versus intravenous pantoprazole on rebleeding after nonvariceal upper gastroIntestinal bleeding: a pilot study.
• The role of endoscopy in noniatrogenic injuries of the liver.
• Inhibitory control test is a simple method to diagnose minimal hepatic encephalopathy and predict development of overt hepatic encephalopathy.
• Testing for minimal hepatic encephalopathy in the United States: An AASLD survey.
• Safety and feasibility of evaluating airway-protective reflexes during sleep: new technique and preliminary results.
• Impact of Clostridium difficile on inflammatory bowel disease.
• Influence of sleep stages on esophago-upper Esophageal sphincter contractile reflex and secondary Esophageal peristalsis.
• Another indication for transnasal, unsedated upper-GI endoscopy.
• Survey of attitudes of AASLD members toward balloon tamponade.
• Increased rates of early adverse reaction to azathioprine in patients with Crohn''s disease compared to autoimmune Hepatitis: a tertiary referral center experience.
• MELD score does not discriminate against patients with hepatic encephalopathy.
• Esophageal veggie spasms: a food-specific cause of chest distress.
• TIPSS as therapeutic modality for umbilical Hernia in patients with advanced liver disease.
• Pretreatment laparoscopic appearance of the liver can predict response to combination therapy with interferon alpha 2B and ribavirin in chronic Hepatitis C.
• Should a radiological diagnosis of hepatocellular carcinoma be routinely confirmed by a biopsy? No.
• Pathogenesis and diagnosis of hepatic encephalopathy.
• Management options for minimal hepatic encephalopathy.
• Minimal hepatic encephalopathy matters in daily life.
• The irony of herbal Hepatitis: Ma-Huang-induced hepatotoxicity associated with compound heterozygosity for hereditary hemochromatosis.
• High-dose vitamin E supplementation does not diminish ribavirin-associated haemolysis in Hepatitis C treatment with combination standard alpha-interferon and ribavirin.
• Postoperative management of noniatrogenic traumatic bile duct injuries: role of endoscopic retrograde cholangiopancreaticography.

Procedures Preformed

---

• Colonoscopy, Proctosigmoidoscopy, and Sigmoidoscopy

Conditions Treated

---

• Anemia
• Cirrhosis
• Diaphragmatic and-or Hiatal Hernia
• Diverticulosis, Intestinal
• View All

Doctors Specialties

---

• Gastroenterology
• Transplant Hepatology

Accepted Insurances

---

Education

---

• Medical College of Wisconsin Affiliated Hospitals
• SUNY Health Science Center at Brooklyn
• Maulana Azad Medical College

Helpful Reviews

---

Give Anonymous Review

Similar Doctors

---

	Dr. Zahid Rashid, MD This Doctor is OpenDoctor Recommended.
	Dr. Wiley J. Latham, MD This Doctor is OpenDoctor Recommended.
	Dr. Puneet Kumar, MD This Doctor is OpenDoctor Recommended.
	Dr. David J. McGroarty, MD This Doctor is OpenDoctor Recommended.
	Dr. Michael T. Farrell, MD This Doctor is OpenDoctor Recommended.
	Dr. John F. Kuemmerle, MD This Doctor is OpenDoctor Recommended.
	Dr. Wenhuan S. Ho, MD This Doctor is OpenDoctor Recommended.
	Dr. Doumit S. Bouhaidar, MD This Doctor is OpenDoctor Recommended.
	Dr. Velimir A. Luketic, MD This Doctor is OpenDoctor Recommended.
	Dr. Puneet Puri, MD This Doctor is OpenDoctor Recommended.
	Dr. Yiping Rao, MD This Doctor is OpenDoctor Recommended.
	Dr. Sanjeev K. Jairath, MD This Doctor is OpenDoctor Recommended.
	Dr. Kishor Kumar K. Muniyappa, MD This Doctor is OpenDoctor Recommended.
	Dr. Gregory K. Lemite, MD This Doctor is OpenDoctor Recommended.
	Dr. Jill K. Gaidos, MD This Doctor is OpenDoctor Recommended.
	Dr. Ashwani Kapoor, MD This Doctor is OpenDoctor Recommended.
	Dr. Nevin Yilmaz, MD
	Mankanchan S. Majhail, FNP This Doctor is OpenDoctor Recommended.
	Reena Cherian, FNP This Doctor is OpenDoctor Recommended.

---

Doctor Directory | TOS | twitter | FB | Angel | blog